Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Kymera Therapeutics, Inc. (KYMR) has a Wall Street consensus price target of $117.31, based on estimates from 26 covering analysts. With the stock currently trading at $91.35, this represents a potential upside of +28.4%. The company has a market capitalization of $7.43B.
Analyst price targets range from a low of $90.00 to a high of $138.00, representing a 41% spread in expectations. The median target of $119.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 23 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, KYMR trades at a trailing P/E of -24.8x. Analysts expect EPS to grow +1.3% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how KYMR stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for KYMR is $117.31, representing 28.4% upside from the current price of $91.35. With 26 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
KYMR has a consensus rating of "Buy" based on 26 Wall Street analysts. The rating breakdown is predominantly bullish, with 23 Buy/Strong Buy ratings. The consensus 12-month price target of $117.31 implies 28.4% upside from current levels.
KYMR's current price is $91.35 with a consensus target of $117.31 (28.4% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $138 for KYMR, while the most conservative target is $90. The consensus of $117.31 represents the median expectation. These targets typically reflect 12-month expectations.
KYMR is heavily covered by Wall Street, with 26 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 23 have Buy ratings, 3 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month KYMR stock forecast based on 26 Wall Street analysts shows a consensus price target of $117.31, with estimates ranging from $90 (bear case) to $138 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on KYMR, with a "Buy" consensus rating and $117.31 price target (28.4% upside). 23 of 26 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
KYMR analyst price targets range from $90 to $138, a 41% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $117.31 consensus represents the middle ground.